Spots Global Cancer Trial Database for A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
Official Title: An Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE in Patients With Relapsed Multiple Myeloma Who Have Failed Four or More Lines of Therapy
Study ID: NCT00063791
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to give patients who have had 4 or more prior lines of therapy for multiple myeloma access to VELCADE. The study is for patients who are not eligible for other clinical trials with VELCADE and for who VELCADE would otherwise not be available.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Michael Meshad, Oncology Center, Mobile, Alabama, United States
Henry Ford Health System, Detroit, Michigan, United States
Toledo Clinic, Toledo, Ohio, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
